HAEMONETICS CORP - Common Stock (HAE)

CUSIP: 405024100

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock
Shares outstanding
46,480,294
Total 13F shares
50,672,122
Share change
+1,668,800
Total reported value
$3,375,443,272
Put/Call ratio
100%
Price per share
$66.64
Number of holders
249
Value change
-$52,557,812
Number of buys
149
Number of sells
158

Quarterly Holders Quick Answers

What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of HAE - HAEMONETICS CORP - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Capital Research Global Investors
13F
Company
13%
6,217,498
$690,204,000 31 Mar 2021
13F
VANGUARD GROUP INC
13F
Company
11%
4,883,613
$542,130,000 31 Mar 2021
13F
BlackRock Finance, Inc.
13F
Company
10%
4,797,606
$532,581,000 31 Mar 2021
13F
Neuberger Berman Group LLC
13F
Company
6.1%
2,837,486
$313,849,000 31 Mar 2021
13F
FMR LLC
13F
Company
4.8%
2,251,084
$249,893,000 31 Mar 2021
13F
FRANKLIN RESOURCES INC
13F
Company
4%
1,862,710
$206,780,000 31 Mar 2021
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
3.1%
1,427,334
$158,449,000 31 Mar 2021
13F
Capital World Investors
13F
Company
2.8%
1,287,600
$142,936,000 31 Mar 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.8%
1,280,094
$142,103,000 31 Mar 2021
13F
STATE STREET CORP
13F
Company
2.6%
1,227,079
$136,218,000 31 Mar 2021
13F
LONDON CO OF VIRGINIA
13F
Company
2.3%
1,057,738
$117,420,000 31 Mar 2021
13F
EATON VANCE MANAGEMENT
13F
Company
2.2%
1,035,553
$114,957,000 31 Mar 2021
13F
ORBIMED ADVISORS LLC
13F
Company
1.8%
852,000
$94,581,000 31 Mar 2021
13F
AMERIPRISE FINANCIAL INC
13F
Company
1.6%
755,424
$83,860,000 31 Mar 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.3%
617,413
$68,539,000 31 Mar 2021
13F
MORGAN STANLEY
13F
Company
1.2%
579,658
$64,347,000 31 Mar 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.2%
552,072
$61,286,000 31 Mar 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
1.2%
550,572
$61,118,000 31 Mar 2021
13F
WADDELL & REED FINANCIAL INC
13F
Company
1.2%
539,387
$59,877,000 31 Mar 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.1%
504,105
$55,964,000 31 Mar 2021
13F
Bank of New York Mellon Corp
13F
Company
1.1%
490,784
$54,482,000 31 Mar 2021
13F
ROYCE & ASSOCIATES LP
13F
Company
1%
468,585
$52,018,000 31 Mar 2021
13F
Gestion Carmignac
13F
Individual
0.95%
440,139
$48,860,000 31 Mar 2021
13F
NORTHERN TRUST CORP
13F
Company
0.94%
438,210
$48,646,000 31 Mar 2021
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
0.93%
430,777
$47,821,000 31 Mar 2021
13F
NORGES BANK
13F
Company
0.93%
430,417
$47,781,000 31 Mar 2021
13F
ANCHOR CAPITAL ADVISORS LLC
13F
Company
0.89%
412,218
$45,760,000 31 Mar 2021
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.82%
380,548
$42,245,000 31 Mar 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.78%
364,059
$40,414,000 31 Mar 2021
13F
Polar Capital Holdings Plc
13F
Company
0.73%
338,576
$37,585,000 31 Mar 2021
13F
Iron Triangle Partners LP
13F
Company
0.71%
330,000
$36,633,000 31 Mar 2021
13F
Holocene Advisors, LP
13F
Company
0.68%
315,739
$35,050,000 31 Mar 2021
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.64%
298,360
$33,121,000 31 Mar 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.63%
293,009
$32,527,000 31 Mar 2021
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.58%
267,433
$29,688,000 31 Mar 2021
13F
Aristotle Capital Boston, LLC
13F
Company
0.57%
263,728
$29,276,000 31 Mar 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.54%
250,469
$27,806,000 31 Mar 2021
13F
AEGON ASSET MANAGEMENT UK PLC
13F
Company
0.52%
242,493
$26,919,000 31 Mar 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.5%
231,891
$25,743,000 31 Mar 2021
13F
Boston Trust Walden Corp
13F
Company
0.49%
229,055
$25,428,000 31 Mar 2021
13F
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO
13F
Company
0.48%
224,226
$24,891,000 31 Mar 2021
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.43%
199,831
$22,184,000 31 Mar 2021
13F
Invesco Ltd.
13F
Company
0.43%
198,102
$21,992,000 31 Mar 2021
13F
Point72 Asset Management, L.P.
13F
Company
0.41%
189,700
$21,059,000 31 Mar 2021
13F
ROYAL BANK OF CANADA
13F
Company
0.41%
188,516
$20,927,000 31 Mar 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.4%
187,361
$20,799,000 31 Mar 2021
13F
THORNBURG INVESTMENT MANAGEMENT INC
13F
Company
0.37%
170,153
$18,889,000 31 Mar 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.36%
168,455
$18,700,000 31 Mar 2021
13F
BEACONLIGHT CAPITAL, LLC
13F
Company
0.34%
156,395
$17,361,000 31 Mar 2021
13F
AMERICAN CAPITAL MANAGEMENT INC
13F
Company
0.33%
153,245
$17,012,000 31 Mar 2021
13F

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2021

As of 30 Jun 2021, HAEMONETICS CORP - Common Stock (HAE) was held by 249 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,672,122 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Neuberger Berman Group LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, STATE STREET CORP, FRANKLIN RESOURCES INC, Fisher Asset Management, LLC, LONDON CO OF VIRGINIA, and LGT CAPITAL PARTNERS LTD.. This page lists 249 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
288
Q2 2021 holders
249
Holder diff
-39
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 Value $ Q2 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.